Imperagen
It develops AI and quantum-powered enzyme engineering technology and is using seed funding to scale its platform.
Overview
Imperagen is a Manchester-based deep tech company building an AI and quantum-powered approach to enzyme engineering. Its work targets customers and partners seeking engineered enzymes, with the company positioning its platform around computational methods for enzyme design and development. The company raised a €5.8 million Seed round, listed as about $6 million, in May 2026. The financing is intended to help scale its enzyme engineering platform and supports its differentiation at the intersection of artificial intelligence, quantum computing and biotechnology.
Funding History
Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering
Frequently Asked Questions
- How much has Imperagen raised in total?
- Imperagen has raised a total of $6M across 1 funding round.
- Who are Imperagen's investors?
- Imperagen's investors include Undisclosed.
- What does Imperagen do?
- Imperagen is a Manchester-based deep tech company building an AI and quantum-powered approach to enzyme engineering. Its work targets customers and partners seeking engineered enzymes, with the company positioning its platform around computational methods for enzyme design and development. The company raised a €5.8 million Seed round, listed as about $6 million, in May 2026. The financing is intended to help scale its enzyme engineering platform and supports its differentiation at the intersection of artificial intelligence, quantum computing and biotechnology.
- Where is Imperagen headquartered?
- Imperagen is headquartered in Manchester, United Kingdom.
Investors
Related Insights
The definitive guide to AI startup funding in 2026 — from pre-seed through IPO, covering valuation mechanics, timelines, investor expectations, and how AI companies differ from traditional tech startups.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.